O044 GVHD and GFRS in patients with AML undergoing allogeneic transplantation with treosulfan- versus busulfan-based conditioning: a subgroup analysis of the randomized phase III MC-FludT.14/L trial

Stoelzel, F. and Stelljes, M. and Beelen, D. and Markiewicz, M. and Remenyi, P. and Dreger, P. and Ciceri, F. and Wagner-Drouet, E. M. and Junghanss, C. and Scheid, C. and Patriarca, F. and Socie, G. and Hilgendorf, I. and Rambaldi, A. and Schaefer-Eckart, K. and Russo, D. and Grigoleit, G. U. and Wulf, G. and Basara, N. and Glass, B. and Labussiere-Wallet, H. and Stuhler, G. and Bieniaszewska, M. and Casper, J. and Holler, Ernst and Benedetti, F. and Iori, A. P. and Trenschel, R. and Bethge, W. (2022) O044 GVHD and GFRS in patients with AML undergoing allogeneic transplantation with treosulfan- versus busulfan-based conditioning: a subgroup analysis of the randomized phase III MC-FludT.14/L trial. In: 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), March 19-23, 2022, Czech Republik.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Speech)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User:	Petra Gürster
Date Deposited:	01 Sep 2023 05:24
Last Modified:	01 Sep 2023 05:24
URI:	https://pred.uni-regensburg.de/id/eprint/58590

Actions (login required)

View Item